BRIEF published on 05/30/2025 at 01:05, 8 months 6 days ago BioNxt Solutions met à jour le statut de l'ordonnance de cessation d'opérations de la direction MCTO BCSC Solutions BioNxt Dépôt De Documents Financiers Progression De L'audit
PRESS RELEASE published on 05/30/2025 at 01:00, 8 months 6 days ago BioNxt Solutions Provides Bi-weekly MCTO Status Report BioNxt Solutions Inc. announces management cease trade order by BCSC until required financial statements are filed. Company's progress on compliance and commitment to regulation outlined Financial Statements Regulatory Compliance Management Cease Trade Order BCSC BioNxt Solutions Inc.
BRIEF published on 05/23/2025 at 09:10, 8 months 13 days ago BioNxt Solutions Set to Receive European Patent for Drug Delivery System Drug Development Multiple Sclerosis European Patent BioNxt Solutions Sublingual Delivery
BRIEF published on 05/23/2025 at 09:10, 8 months 13 days ago BioNxt Solutions s'apprête à obtenir un brevet européen pour son système d'administration de médicaments Sclérose En Plaques Développement De Médicaments Solutions BioNxt Brevet Européen Administration Sublinguale
PRESS RELEASE published on 05/23/2025 at 09:05, 8 months 13 days ago BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent BioNxt Solutions Inc. announces European Patent Office's intention to grant their core patent for advanced drug delivery systems, focusing on sublingual anticancer treatments BioNxt Solutions Inc. European Patent Office Drug Delivery Systems Sublingual Anticancer Treatments
BRIEF published on 05/16/2025 at 01:35, 8 months 20 days ago BioNxt Solutions Provides MCTO Status Update Financial Statements Regulatory Compliance Shareholder Information MCTO Audit Process
BRIEF published on 05/16/2025 at 01:35, 8 months 20 days ago BioNxt Solutions fournit une mise à jour du statut MCTO MCTO États Financiers Conformité Réglementaire Processus D'audit Informations Aux Actionnaires
PRESS RELEASE published on 05/16/2025 at 01:30, 8 months 20 days ago Bionxt Solutions Provides Bi-Weekly MCTO Status Report BioNxt Solutions Inc. announces a management cease trade order granted by the BC Securities Commission affecting the CEO and CFO from trading until Required Documents filed by June 30, 2025 Management Cease Trade Order BioNxt Solutions Inc. Filing Deadline BC Securities Commission Required Documents
BRIEF published on 05/13/2025 at 09:10, 8 months 23 days ago BioNxt Expands Capabilities with New Munich Lab Integration Drug Delivery Pharmaceutical Innovation BioNxt Solutions BNT23001 Munich Laboratory
BRIEF published on 05/13/2025 at 09:10, 8 months 23 days ago BioNxt étend ses capacités avec l'intégration d'un nouveau laboratoire à Munich Innovation Pharmaceutique Solutions BioNxt Administration De Médicaments BNT23001 Laboratoire De Munich
Published on 02/05/2026 at 23:00, 45 minutes ago Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 2 hours 45 minutes ago Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions
Published on 02/05/2026 at 18:50, 4 hours 55 minutes ago Athena Gold Provides Exploration Update From Nevada and Ontario
Published on 02/05/2026 at 17:35, 6 hours 10 minutes ago Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 19:27, 4 hours 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 4 hours 59 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 5 hours 36 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 5 hours 50 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 6 hours 5 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 19:15, 4 hours 30 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 4 hours 30 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 4 hours 30 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
